Equinox Secures $14 Million Investment

Represented Equinox, Inc. in connection with its agreement to receive $14 million of development capital from Equinox I, LLC, an investment firm managed by Flying L Partners, LLC.

Equinox is a medical device company that uses adjustable, non-surgical, non-pharmacologic technologies to treat diseases of the optic nerve such as glaucoma, by balancing intraocular pressure with intracranial pressure.